CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Stock Options and Warrants (Tables)

3 Months Ended

Aug. 31, 2018

The following table represents stock option and warrant activity as of and for the three months ended August 31, 2018:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options and warrants outstanding—May 31, 2018		132,385,269		$	0.80		3.78	$	3,673

Granted		13,546,582			0.67		—		—
Exercised		—			—		—		—
Forfeited/expired/cancelled		(75,000	)		0.65		—		—

Options and warrants outstanding—August 31, 2018		145,856,851			0.79		3.74		1,710,190

Outstanding exercisable—August 31, 2018		141,382,362		$	0.79		3.58	$	1,200,567